823202-99-9
Chemical Structure
Dipeptide diaminobutyroyl benzylamide diacetate
- CAS No.: 823202-99-9
- Formula:C23H37N5O7
- Molecular Weight:495.57
IUPAC Name: (S)-N-((S)-4-amino-1-(benzylamino)-1-oxobutan-2-yl)-1-(3-aminopropanoyl)pyrrolidine-2-carboxamide diacetate
InChIKey: HSUGRPOJOBRRBK-SXBSVMRRSA-N
SMILES: CC(O)=O.O=C(NCC1=CC=CC=C1)[C@H](CCN)NC([C@H]2N(CCC2)C(CCN)=O)=O.CC(O)=O
Biological Activity: Dipeptide diaminobutyroyl benzylamide diacetate, a Wagerlin-1-mimicking peptide, is a nAChR antagonist. Dipeptide diaminobutyroyl benzylamide diacetate mimics Waglerin-1 to block neuromuscular junction nicotinic acetylcholine receptors, partially inhibits neuronal signal transduction, and relaxes muscles. Dipeptide diaminobutyroyl benzylamide diacetate reduces appearance of facial wrinkles linked to repeated muscle movement.Dipeptide diaminobutyroyl benzylamide diacetate can be used for the research of mild-to-moderate fine and coarse periocular and perioral wrinkles and periorbital ageing[1][2].
| Cat. No. | Nom du produit | Pureté | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Dipeptide diaminobutyroyl benzylamide diacetate | 99.72% | Dipeptide diaminobutyroyl benzylamide diacetate, a Wagerlin-1-mimicking peptide, is a nAChR antagonist. Dipeptide diaminobutyroyl benzylamide diacetate mimics Waglerin-1 to block neuromuscular junction nicotinic acetylcholine receptors, partially inhibits neuronal signal transduction, and relaxes muscles. Dipeptide diaminobutyroyl benzylamide diacetate reduces appearance of facial wrinkles linked to repeated muscle movement.Dipeptide diaminobutyroyl benzylamide diacetate can be used for the research of mild-to-moderate fine and coarse periocular and perioral wrinkles and periorbital ageing. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Trookman NS, et al. Immediate and Long-term Clinical Benefits of a Topical Treatment for Facial Lines and Wrinkles. J Clin Aesthet Dermatol. 2009;2(3):38-43. [Content Brief]
- [2]. D'Arcangelis A, et al. In vitro, ex vivo, instrumental and clinical evaluation of a topical cream on the signs of periorbital ageing. Int J Cosmet Sci. 2025;47(1):18-30. [Content Brief]
